Literature DB >> 22902808

Role of early cell-free DNA levels decrease as a predictive marker of fatal outcome after severe traumatic brain injury.

Hada Macher1, Juan J Egea-Guerrero, Jaume Revuelto-Rey, Elena Gordillo-Escobar, Judy Enamorado-Enamorado, Antonio Boza, Ana Rodriguez, Patrocinio Molinero, Juan M Guerrero, José Maria Dominguez-Roldán, Francisco Murillo-Cabezas, Amalia Rubio.   

Abstract

INTRODUCTION: Circulating cell-free DNA levels are increased after trauma injury. This increase is higher since the first hours after trauma and may be related with primary outcome. A sensitive and reliable biomarker for patients at higher risk is needed to identify these patients to initiate early intervention. In this way, circulating DNA may be a possible biological marker after severe TBI.
MATERIALS AND METHODS: We investigated DNA plasma concentrations after severe traumatic brain injury and during the next 96 h in the Intensive Care Unit (ICU) by real time PCR. 65 patients suffering severe TBI were included in the study.
RESULTS: Cell-free DNA levels were considerably higher in patients samples compared with voluntary control ones. After the following four days we observed a 51% decrease during the first 24h and a 71% fall from 48 h. TBI population was stratified for the primary outcome (survivors/non-survivor) and DNA levels decrease ratio was calculated for the first 48 h. A higher decrease in the survivors from 0 h to 24h compared with the non-survivors was found. A cut-off point of 1.95 ratio was established for the detection of the highest proportions of patients after the TBI that will not survive after the injury with a sensitivity of 70% and specificity of 66%.
CONCLUSIONS: In summary we showed that severe TBI is associated with elevated cf-DNA levels and we propose that cf-DNA decrease during the first 24h may predict patient outcome.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22902808     DOI: 10.1016/j.cca.2012.08.001

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  36 in total

Review 1.  Liquid Biopsies in the Screening of Oncogenic Mutations in NSCLC and its Application in Targeted Therapy.

Authors:  Jason H Tang; David Chia
Journal:  Crit Rev Oncog       Date:  2015

Review 2.  Tumor DNA: an emerging biomarker in head and neck cancer.

Authors:  Joseph A Bellairs; Rifat Hasina; Nishant Agrawal
Journal:  Cancer Metastasis Rev       Date:  2017-09       Impact factor: 9.264

Review 3.  A historical and evolutionary perspective on the biological significance of circulating DNA and extracellular vesicles.

Authors:  Janine Aucamp; Abel J Bronkhorst; Christoffel P S Badenhorst; Piet J Pretorius
Journal:  Cell Mol Life Sci       Date:  2016-09-20       Impact factor: 9.261

Review 4.  Liquid biopsies: genotyping circulating tumor DNA.

Authors:  Luis A Diaz; Alberto Bardelli
Journal:  J Clin Oncol       Date:  2014-01-21       Impact factor: 44.544

5.  Quantitative analysis of individual cell-free DNA concentration before and after penetrating trauma.

Authors:  Katrin Brodbeck; Stefanie Kern; Sylvia Schick; Arnd Steinbrück; Michael Schwerer; Birgit Bayer; Katja Anslinger; Steffen Peldschus
Journal:  Int J Legal Med       Date:  2018-10-16       Impact factor: 2.686

6.  Elevated cell-free plasma DNA level as an independent predictor of mortality in patients with severe traumatic brain injury.

Authors:  Edison Moraes Rodrigues Filho; Daniel Simon; Nilo Ikuta; Caroline Klovan; Fernando Augusto Dannebrock; Carla Oliveira de Oliveira; Andrea Regner
Journal:  J Neurotrauma       Date:  2014-08-04       Impact factor: 5.269

Review 7.  Testing for oncogenic molecular aberrations in cell-free DNA-based liquid biopsies in the clinic: are we there yet?

Authors:  Jiri Polivka; Martin Pesta; Filip Janku
Journal:  Expert Rev Mol Diagn       Date:  2015-11-11       Impact factor: 5.225

8.  High Interspecimen Variability in Nucleic Acid Extraction Efficiency Necessitates the Use of Spike-In Control for Accurate qPCR-based Measurement of Plasma Cell-Free DNA Levels.

Authors:  Grant C O'Connell; Paul D Chantler; Taura L Barr
Journal:  Lab Med       Date:  2017-11-08

9.  Comparison of clinical and inflammatory parameters in dogs with pyometra before and after ovariohysterectomy.

Authors:  Soomin Ahn; Hyeona Bae; Jihu Kim; Suhee Kim; Jinho Park; Sang-Ki Kim; Dong-In Jung; DoHyeon Yu
Journal:  Can J Vet Res       Date:  2021-10       Impact factor: 1.310

10.  Biological variability of cell-free DNA in healthy females at rest within a short time course.

Authors:  Katrin Brodbeck; Sylvia Schick; Birgit Bayer; Katja Anslinger; Kimberly Krüger; Zsuzsanna Mayer; Stefan Holdenrieder; Steffen Peldschus
Journal:  Int J Legal Med       Date:  2020-01-03       Impact factor: 2.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.